Phase IB trial of carboxyamidotriazole rotate (CTO) and temozolamide for recurrent malignant glioma (MG): A novel mechanism for modulation of multiple oncogenic pathways Meeting Abstract
| Authors: | Omuro, A. M. P.; Kaley, T. J.; Pentsova, E.; Deangelis, L. M.; Urba, W. J.; Taylor, M. H.; Anderson, B. D.; Gorman, G.; McLean, S.; Karmali, R. A. |
| Abstract Title: | Phase IB trial of carboxyamidotriazole rotate (CTO) and temozolamide for recurrent malignant glioma (MG): A novel mechanism for modulation of multiple oncogenic pathways |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202736 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.2071 |
| Notes: | Meeting Abstract: 2071 -- Source: Wos |
